News

Sales Focus Inc. Generates $4.2 Million in Revenue for Inside Sales Clients in First Half of 2024

Sales Focus Inc., the sales outsourcing pioneer, announced that its United States-based Inside Sales Center has generated $4.2 million in…

1 year ago

ScaleHealthTech welcomes Industry Veteran Dr. Feby Abraham to its advisory board as a Chief Advisor

ATLANTA, Sept. 6, 2024 /PRNewswire/ -- ScaleHealthTech, a boutique Health IT consulting and digital transformation specialist, today announced that Dr.…

1 year ago

Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

SAN DIEGO and CALGARY, AB, Sept. 6, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing…

1 year ago

Zepp Health Corporation Announces Plan to Implement ADS Ratio Change

MILPITAS, Calif., Sept. 6, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in…

1 year ago

Weekly Recap: 10 Health Press Releases You Might Have Missed

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including a new COVID-19 vaccine, Prostate…

1 year ago

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

WASHINGTON, Sept. 06, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60P” or the “Company”), a pharmaceutical…

1 year ago

Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium

New clinical efficacy and safety data for arimoclomol as a possible treatment for Niemann-Pick disease type C, including from long-term…

1 year ago

Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences

SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based…

1 year ago

Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims

New Patent is Added to the Company’s Portfolio of Formulations that Rapidly Reduce Blood Alcohol Content JUPITER, Fla., Sept. 06,…

1 year ago

Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease

Results from this trial are expected in 2025SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX)…

1 year ago